About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.19.642016860128.2845
Domestic EquitiesDivi's Laboratories Ltd.9.11531985213.1261
Domestic EquitiesMAX Healthcare Institute Ltd9.079611619813.0746
Domestic EquitiesCipla Ltd.8.95238795412.8914
Domestic EquitiesDr. Reddy's Laboratories Ltd.8.28799538511.9346
Domestic EquitiesApollo Hospitals Enterprise Ltd.7.55131580410.8739
Domestic EquitiesLupin Ltd.5.1381377947.3989
Domestic EquitiesFortis Healthcare Ltd.3.9960814705.7542
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.6077163645.1951
Domestic EquitiesAurobindo Pharma Ltd.3.4833437015.0160
Domestic EquitiesMankind Pharma Ltd3.0284176724.3609
Domestic EquitiesAlkem Laboratories Ltd.2.948683284.2460
Domestic EquitiesLaurus Labs Ltd.2.5903611873.7300
Domestic EquitiesZydus Lifesciences Ltd.2.5210390363.6303
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.3804235253.4278
Domestic EquitiesIPCA Laboratories Ltd.2.1483217123.0935
Domestic EquitiesAbbott India Ltd.1.72378152.4821
Domestic EquitiesBiocon Ltd.1.6421704102.3647
Domestic EquitiesSyngene International Ltd.1.3273295611.9113
Domestic EquitiesGranules India Ltd.0.8347226531.2019
Total 99.9983 143.9978
Cash & Cash Equivalents and Net AssetsTREPS0.4967 0.7153
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.4950 -0.7129
Total 0.0017 0.0024
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.